Ehlert v. Singer

185 F.R.D. 674, 44 Fed. R. Serv. 3d 1104, 1999 U.S. Dist. LEXIS 6180, 1999 WL 253206
CourtDistrict Court, M.D. Florida
DecidedApril 19, 1999
DocketNo. 98-2168-Civ—T—17E
StatusPublished
Cited by4 cases

This text of 185 F.R.D. 674 (Ehlert v. Singer) is published on Counsel Stack Legal Research, covering District Court, M.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Ehlert v. Singer, 185 F.R.D. 674, 44 Fed. R. Serv. 3d 1104, 1999 U.S. Dist. LEXIS 6180, 1999 WL 253206 (M.D. Fla. 1999).

Opinion

[676]*676 ORDER ON MOTION FOR APPOINTMENT OF LEAD PLAINTIFFS AND APPROVAL OF PLAINTIFFS’ SELECTION OF CO-LEAD COUNSEL AND LIAISON COUNSEL

KOVACHEVICH, Chief Judge.

THIS CAUSE is before the Court on Plaintiffs’, GEORGE EHLERT AND GEORGEANNE EHLERT, Motion for Appointment of Lead Plaintiffs and Approval of Plaintiffs’ Selection of Co-Lead Counsel and Liaison Counsel filed on December 21, 1998. (Docket Nos. 19 & 20). The Defendants, MICHAEL A. SINGER, et al. (“MMC”), filed responses to the motion on January 11, 1999 and January 12, 1999. (Docket Nos. 27 & 28). The motion is filed as required by the guidelines of Rule 23 of the Federal Rules of Civil Procedure and § 27 of the Securities Act of 1933 codified in 1995 within 15 U.S.C. 77z-l(a)(3)(B).

STANDARD OF REVIEW

This motion is governed by the Securities Act of 1933 (“the Act”), 15 U.S.C. § 77z-l(a), and Fed.R.Civ.P. 23. The Act provides that in “each private action arising under [the Exchange Act] that is brought as a plaintiff class action pursuant to the Federal Rules of Civil Procedure,” 15 U.S.C. § 77&-l(a)(l), the Court shall appoint a lead plaintiff. § 77z-l(a)(3)(B)(i). The lead plaintiff shall be that member of the “plaintiff class the Court determines to be most capable of adequately representing the interests of the class members (the ‘most adequate plaintiff).” /d'The Court shall consider any timely motion for appointment as lead plaintiff by any member of the purported class. Id.

The Act creates a rebuttable assumption where the most adequate plaintiff is the one who has satisfied three requirements. § 77z-l(a)(3)(B)(iii)(I). That a person: (1) “has either filed the complaint or made a motion in response to a notice,” § 77z-l(a)(3)(B)(iii)(I)(aa); (2) “has the largest financial interest in the relief sought,” § 77z-l(a)(3)(B)(iii)(I)(bb); (3) and “otherwise satisfies the requirements of Rule 23 of the Federal Rules of Civil Procedure,” § 77z-l(a)(3)(B)(iii)(I)(cc). Any member of the purported plaintiff class may rebut the presumption upon proof the proposed lead plaintiff “is subject to unique defenses,” § 77z-1(a) (3)(B) (iii) (II) (bb), or “will not fairly and adequately protect the interests of the class,” § 77z-l(a)(3)(B)(iii)(II)(aa). Discovery may be had on the issue only upon a showing of a reasonable basis for a finding the presumptive most adequate plaintiff cannot adequately represent the class. § 77z-l(a)(3)(B)(iv).

BACKGROUND

The Plaintiffs filed a complaint and demand for jury trial on October 23, 1998. (Docket No. 1). On December 9, 1998, the Defendants filed motions for an extension of time. (Docket Nos. 3 & 4). This Court granted motions and extended the responses to the complaint until January 22, 1999, for the underwriter defendants, and January 28, 1999, for the remaining defendants. (Docket Nos. 23 & 24).

The Plaintiffs filed this motion for the appointment of lead plaintiff and lead counsel, on December 21, 1998. (Docket Nos. 19 & 20). The Defendants responded to the motion by neither taking a position nor opposing the plaintiffs’ motion to appoint lead plaintiff and lead counsel. (Docket Nos. 27 & 28).

The complaint alleges the following:

1. Plaintiffs bring this security class action on behalf of themselves and all other similarly situated purchasers of the common stock of Medical Manager Corpora-' tion (“MMC”). (Docket No. 1, Paragraph 2).
2. The plaintiffs allege violations of the federal securities laws arising out of the Company’s issuance of materially false and misleading statements concerning its business operations, including the development and sale of its principal product during the class period. (Docket No. 1, Paragraph 2).
3. MMC holds itself out to the market as a leading provider of computer management information systems to the healthcare industry. (Docket No. 1, Paragraph 3).
4. The Medical Manager system is primarily a suite of computer software [677]*677products that addresses the financial, administrative and other management requirements of a health professional’s practice. (Docket No. 1, Paragraph 3).
5. Since 1994, MMC has been selling its software system known as “Version 8” of the Medical Manager System. (Docket No. 1, Paragraph 3).
6. In February of 1997, MMC became a public company through an initial public offering, with its common stock traded thereafter on the National Association of Securities Dealers Automated Quotation (“NASDAQ”) National Market System. (Docket No. 1, Paragraph 4).
7. By means of a registration statement and prospectus dated April 23, 1998 (“Prospectus”), defendants conducted a secondary public offering of 2.5 million shares of MMC securities. (Docket No. 1, Paragraph 4).
8. The April 23, 1998 prospectus offered to sell an additional 1.5 million shares of its common stock to the public at a price of $30.00 per share (“Offering”). (Docket No. I, Paragraph 4).
8. The Company’s two founders, defendant Michael Singer, MMC’s Chairman of the Board and Chief Executive Officer, and defendant Richard Mehrlieh, an MMC director, each sold 500,000 shares of common stock in the Offering from which they received proceeds in excess of $28 million. (Docket No. 1, Paragraph 4).
9. The prospectus did not mention that the company intended to shorten the life span of MMC’s Version 8 system (with technical support for this product being substantially curtailed). (Docket No. 1, Paragraph 5).
10. MMC did not disclose publicly that it intended to render this product known as “Version 9”. (Docket No. 1, Paragraph- 5).
II. In the prospectus, MMC’s version 9 system was touted by the company as being “Year 2000 compliant”, whereas its Version 8 system contains a software defect known as the “millennium bug” or “Year 2000 Problem”. (Docket No. 1, Paragraph 5).
12. Without knowledge to investors, MMC intended to terminate support for its customers using the Version 8 product. (Docket No. 1, Paragraph 5).
13. On August 5, 1998 and confirmed by MMC on August 6, 1998, it was disclosed that a customer had initiated a legal action against the company based upon the company’s failure to address the Year 2000 defect in Version 8. (Docket No. 1, Paragraph 6).
14.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Newman v. Eagle Building Technologies
209 F.R.D. 499 (S.D. Florida, 2002)
Piven v. Sykes Enterprises, Inc.
137 F. Supp. 2d 1295 (M.D. Florida, 2000)

Cite This Page — Counsel Stack

Bluebook (online)
185 F.R.D. 674, 44 Fed. R. Serv. 3d 1104, 1999 U.S. Dist. LEXIS 6180, 1999 WL 253206, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ehlert-v-singer-flmd-1999.